Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Results from 96 Weeks Open-Label Extension of a Phase 2 Trial of Losmapimod in Subjects with FSHD: ReDUX4

Author:Wang, Leo   Han, Jay   Shoskes, Jennifer   Jiang, John   Tawil, Alrabi   

Session Name:S48: Therapeutics for Muscle Disease  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S48.008  

Author Institution:University of Washington, Seattle, WA  UCI Medical Center, Orange, CA  Fulcrum Therapeutics, Cambridge, MA  University of Rochester Medical Center, Rochester, NY